Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 20430461)

1.

Clinical introduction of Monte Carlo treatment planning: a different prescription dose for non-small cell lung cancer according to tumor location and size.

van der Voort van Zyp NC, Hoogeman MS, van de Water S, Levendag PC, van der Holt B, Heijmen BJ, Nuyttens JJ.

Radiother Oncol. 2010 Jul;96(1):55-60. doi: 10.1016/j.radonc.2010.04.009. Epub 2010 Apr 27.

PMID:
20430461
2.

Stereotactic, single-dose irradiation of lung tumors: a comparison of absolute dose and dose distribution between pencil beam and Monte Carlo algorithms based on actual patient CT scans.

Chen H, Lohr F, Fritz P, Wenz F, Dobler B, Lorenz F, Mühlnickel W.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):955-63. doi: 10.1016/j.ijrobp.2009.08.012. Epub 2010 Feb 18.

PMID:
20171796
3.

Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT).

Rassiah-Szegedi P, Salter BJ, Fuller CD, Blough M, Papanikolaou N, Fuss M.

Acta Oncol. 2006;45(7):989-94.

PMID:
16982568
4.

Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.

Li J, Galvin J, Harrison A, Timmerman R, Yu Y, Xiao Y.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):508-13. doi: 10.1016/j.ijrobp.2011.12.005. Epub 2012 Feb 24.

5.

3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer.

van Elmpt W, Petit S, De Ruysscher D, Lambin P, Dekker A.

Radiother Oncol. 2010 Feb;94(2):188-94. doi: 10.1016/j.radonc.2009.12.024. Epub 2010 Jan 18.

PMID:
20083317
6.

Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy.

Zhuang T, Djemil T, Qi P, Magnelli A, Stephans K, Videtic G, Xia P.

J Appl Clin Med Phys. 2013 Mar 4;14(2):4011. doi: 10.1120/jacmp.v14i2.4011.

PMID:
23470930
7.

[Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].

Gong HY, Yu JM, Fu Z, Li BS, Li JB, Liu TH.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):54-7. Chinese.

PMID:
16737623
8.

Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.

Sonke JJ, Rossi M, Wolthaus J, van Herk M, Damen E, Belderbos J.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):567-74. doi: 10.1016/j.ijrobp.2008.08.004. Epub 2008 Nov 27.

PMID:
19046825
9.

Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions.

Lax I, Panettieri V, Wennberg B, Amor Duch M, Näslund I, Baumann P, Gagliardi G.

Acta Oncol. 2006;45(7):978-88.

PMID:
16982567
10.

Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.

van Dam IE, van Sörnsen de Koste JR, Hanna GG, Muirhead R, Slotman BJ, Senan S.

Radiother Oncol. 2010 Jul;96(1):67-72. doi: 10.1016/j.radonc.2010.05.003.

PMID:
20570381
12.

Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.

van der Voort van Zyp NC, Prévost JB, Hoogeman MS, Praag J, van der Holt B, Levendag PC, van Klaveren RJ, Pattynama P, Nuyttens JJ.

Radiother Oncol. 2009 Jun;91(3):296-300. doi: 10.1016/j.radonc.2009.02.011. Epub 2009 Mar 16.

PMID:
19297048
13.

4D imaging for target definition in stereotactic radiotherapy for lung cancer.

Slotman BJ, Lagerwaard FJ, Senan S.

Acta Oncol. 2006;45(7):966-72. Review.

PMID:
16982565
14.

Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.

Galerani AP, Grills I, Hugo G, Kestin L, Mohammed N, Chao KK, Suen A, Martinez A, Yan D.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1571-8. doi: 10.1016/j.ijrobp.2010.02.012. Epub 2010 Jun 18.

PMID:
20646857
15.

Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.

Arvidson NB, Mehta MP, Tomé WA.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1597-603. doi: 10.1016/j.ijrobp.2008.07.048.

PMID:
19028283
16.

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M.

Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29.

PMID:
18514339
17.

Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.

Kadoya N, Obata Y, Kato T, Kagiya M, Nakamura T, Tomoda T, Takada A, Takayama K, Fuwa N.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1225-31. doi: 10.1016/j.ijrobp.2010.05.016. Epub 2010 Aug 21.

PMID:
20732759
18.
19.

Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.

Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):950-8. doi: 10.1016/j.ijrobp.2009.04.023.

PMID:
19801106
20.

Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol.

Elmpt Wv, Ollers M, Velders M, Poels K, Mijnheer B, Ruysscher DD, Dekker A, Lambin P, Boersma L.

Radiother Oncol. 2008 Sep;88(3):326-34. doi: 10.1016/j.radonc.2008.07.003. Epub 2008 Aug 11.

PMID:
18701177
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk